Procedures to fast-track approvals of new vaccines to combat H1N1 influenza do not reduce safety, the World Health Organization said.
Procedures to fast-track approvals of new vaccines to combat H1N1 influenza do not reduce safety, the World Health Organization said.
According to WHO, the current outbreak of H1N1, declared a pandemic on June 11, is the fastest ever pandemic and could eventually affect 2 billion people. It further stated that vaccines had to be available quickly and in large quantities to have the greatest impact.
The United Nations agency said vaccines had arrived too late in the 1957 and 1968 flu pandemics to be of much use, and flu vaccines had not yet been developed in the 1918 Spanish flu pandemic which killed an estimated 50 million people.
WHO has been working with government regulators and vaccine makers in 2007 to look at ways of speeding up the approval of a new vaccine if a fresh virus strain emerged. In some cases the process could be faster because a vaccine was not really new as it was based on the technology for existing seasonal flu vaccines.
Concerns have been expressed about the safety of vaccines to fight H1N1, known as swine flu. The WHO statement emphasized that the public needs to be reassured that regulatory procedures in place for the licensing of pandemic vaccines, including procedures for expediting regulatory approval, are rigorous and do not compromise safety or quality controls.But safety issues could arise during a pandemic when a vaccine is administered on a mass scale, even if they did not show up in safety trials.
For these reasons, WHO has advised all countries administering pandemic vaccines to conduct intensive monitoring for safety and efficacy, and many countries have plans in place for doing so.
According to WHO, the current outbreak of H1N1, declared a pandemic on June 11, is the fastest ever pandemic and could eventually affect 2 billion people. It further stated that vaccines had to be available quickly and in large quantities to have the greatest impact.
The United Nations agency said vaccines had arrived too late in the 1957 and 1968 flu pandemics to be of much use, and flu vaccines had not yet been developed in the 1918 Spanish flu pandemic which killed an estimated 50 million people.
WHO has been working with government regulators and vaccine makers in 2007 to look at ways of speeding up the approval of a new vaccine if a fresh virus strain emerged. In some cases the process could be faster because a vaccine was not really new as it was based on the technology for existing seasonal flu vaccines.
Concerns have been expressed about the safety of vaccines to fight H1N1, known as swine flu. The WHO statement emphasized that the public needs to be reassured that regulatory procedures in place for the licensing of pandemic vaccines, including procedures for expediting regulatory approval, are rigorous and do not compromise safety or quality controls.But safety issues could arise during a pandemic when a vaccine is administered on a mass scale, even if they did not show up in safety trials.
For these reasons, WHO has advised all countries administering pandemic vaccines to conduct intensive monitoring for safety and efficacy, and many countries have plans in place for doing so.
COMMENT
DoctorNDTV is the one stop site for all your health needs providing the most credible health information, health news and tips with expert advice on healthy living, diet plans, informative videos etc. You can get the most relevant and accurate info you need about health problems like diabetes, cancer, pregnancy, HIV and AIDS, weight loss and many other lifestyle diseases. We have a panel of over 350 experts who help us develop content by giving their valuable inputs and bringing to us the latest in the world of healthcare.
